Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Information Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,773 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,607 · Balance 41,401 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,084 · Balance 42,485 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 1,995 · Balance 44,480 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,360 · Balance 45,840 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,067 · Balance 42,773 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,607 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,084 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 7,978 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 1,995 · Balance 7,978 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,162 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,360 · Balance 8,162 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 2, 2024 22:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000084 · wk-form4_1712095699.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,070 Underlying: Common Stock · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 574 | $20.25 | $11,623.50 |
DisclosureSEC source: 0001576280-24-000084 · wk-form4_1712095699.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,755 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 22:08 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000084 · wk-form4_1712095699.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 19, 2024 21:29 UTC | Guardant Health, Inc. GH · Entity 3238 | PurchaseCommon Stock | 2,187 | $17.82 | $38,962.72 |
DisclosureSEC source: 0001576280-24-000065 · wk-form4_1710883734.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,722 Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000051 · wk-form4_1709595337.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,262 Underlying: Common Stock · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 254 | $18.97 | $4,818.38 |
DisclosureSEC source: 0001576280-24-000051 · wk-form4_1709595337.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,535 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 23:35 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000051 · wk-form4_1709595337.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 5,376 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000018 · wk-form4_1704761150.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 5,376 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on January 7, 2021, and the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 7, 2021, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,171 | $25.78 | $55,968.38 |
DisclosureSEC source: 0001576280-24-000018 · wk-form4_1704761150.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,079 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 07, 2024 Filed Jan 9, 2024 00:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 5,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000018 · wk-form4_1704761150.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,607 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000010 · wk-form4_1704329276.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,677 Underlying: COMMON STOCK · 1,607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 659 | $27.05 | $17,825.95 |
DisclosureSEC source: 0001576280-24-000010 · wk-form4_1704329276.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,874 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:48 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-24-000010 · wk-form4_1704329276.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:23 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 12,940 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000215 · wk-form4_1702679002.xml · derivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,940 Underlying: COMMON STOCK · 12,940 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:23 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 19,410 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001576280-23-000215 · wk-form4_1702679002.xml · derivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,410 Underlying: COMMON STOCK · 19,410 shares Expires 2033-12-13 F1 · derivative.exercise_date: This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000199 · wk-form4_1701732329.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,972 Underlying: COMMON STOCK · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F4 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 5,800 | $26.37 | $152,954.12 |
DisclosureSEC source: 0001576280-23-000199 · wk-form4_1701732329.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,926 F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $26.395 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 353 | $26.33 | $9,294.49 |
DisclosureSEC source: 0001576280-23-000199 · wk-form4_1701732329.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,726 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000199 · wk-form4_1701732329.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 6,428 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000171 · wk-form4_1696281736.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,284 Underlying: COMMON STOCK · 6,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,872 | $29.64 | $85,126.08 |
DisclosureSEC source: 0001576280-23-000171 · wk-form4_1696281736.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,369 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:22 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 6,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000171 · wk-form4_1696281736.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 23:11 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 2,125 | $32.59 | $69,253.75 |
DisclosureSEC source: 0001576280-23-000155 · wk-form4_1694646696.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,813 Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 6,544 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000149 · wk-form4_1694469310.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,545 Underlying: COMMON STOCK · 6,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award annually commencing on September 9, 2020. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,263 | $33.72 | $76,308.36 |
DisclosureSEC source: 0001576280-23-000149 · wk-form4_1694469310.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,938 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:55 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 6,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000149 · wk-form4_1694469310.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000137 · wk-form4_1693947138.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,682 Underlying: COMMON STOCK · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 246 | $35.01 | $8,612.46 |
DisclosureSEC source: 0001576280-23-000137 · wk-form4_1693947138.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,657 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:52 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000137 · wk-form4_1693947138.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:42 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 7,609 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000085 · wk-form4_1686692516.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,609 Underlying: COMMON STOCK · 7,609 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:42 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 11,414 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001576280-23-000085 · wk-form4_1686692516.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,414 Underlying: COMMON STOCK · 11,414 shares Expires 2033-06-09 F1 · derivative.exercise_date: This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 9, 2024, and the remaining 67% of the shares vests in equal installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:42 UTC | Guardant Health, Inc. GH · Entity 3238 | PurchaseCOMMON STOCK | 750 | $32.78 | $24,584.25 |
DisclosureSEC source: 0001576280-23-000085 · wk-form4_1686692516.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,193 Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:42 UTC | Guardant Health, Inc. GH · Entity 3238 | PurchaseCOMMON STOCK | 2,231 | $32.68 | $72,913.77 |
DisclosureSEC source: 0001576280-23-000085 · wk-form4_1686692516.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,443 Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000070 · wk-form4_1686001518.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,392 Underlying: COMMON STOCK · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 246 | $31.39 | $7,721.94 |
DisclosureSEC source: 0001576280-23-000070 · wk-form4_1686001518.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,212 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:45 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000070 · wk-form4_1686001518.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 6,500 | $31.92 | $207,466.35 |
DisclosureSEC source: 0001576280-23-000028 · wf-form4_167788074603027.xml · nonDerivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,261 F2 · shares: Represents the weighted average price of shares sold at prices that ranged from $31.87 to $31.99. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 711 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000028 · wf-form4_167788074603027.xml · derivative · entry 4 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Underlying: COMMON STOCK · 711 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F4 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 246 | $29.36 | $7,222.56 |
DisclosureSEC source: 0001576280-23-000028 · wf-form4_167788074603027.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,761 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000028 · wf-form4_167788074603027.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 5,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000007 · wf-form4_167330422648816.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,376 Underlying: COMMON STOCK · 5,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on January 7, 2021, and the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 7, 2021, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,187 | $25.95 | $56,752.65 |
DisclosureSEC source: 0001576280-23-000007 · wf-form4_167330422648816.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,680 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 22:44 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 5,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000007 · wf-form4_167330422648816.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 710 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000110 · wf-form4_167027800131732.xml · derivative · entry 3 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 Underlying: COMMON STOCK · 710 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 353 | $52.41 | $18,500.73 |
DisclosureSEC source: 0001576280-22-000110 · wf-form4_167027800131732.xml · nonDerivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,492 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:07 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 710 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000110 · wf-form4_167027800131732.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 3,125 | $51.87 | $162,082.19 |
DisclosureSEC source: 0001576280-22-000106 · wf-form4_166872514675848.xml · nonDerivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,135 F1 · price: Represents the weighted average price of shares sold at prices that ranged from $51.8535 to $51.95. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 25,712 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000100 · wf-form4_166803336634906.xml · derivative · entry 2 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,712 Underlying: COMMON STOCK · 25,712 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:36 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 51,424 | $0.00 Strike: $47.20 | $0.00 |
DisclosureSEC source: 0001576280-22-000100 · wf-form4_166803336634906.xml · derivative · entry 1 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,424 Underlying: COMMON STOCK · 51,424 shares Expires 2032-11-06 F1 · derivative.exercise_date: This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:14 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 6,544 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000079 · wf-form4_166310002869043.xml · derivative · entry 6 Kalia Kumud · CIK 0001927831 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,089 Underlying: COMMON STOCK · 6,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award annually commencing on September 9, 2020. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.